July 8, 2020— New bipartisan legislation introduced by six senior members of the U.S. Senate would protect hospitals from losing eligibility for the 340B drug pricing program during the COVID-19 health emergency. The bill (S. 4160) was introduced July 2 by Sen. John Thune (R-S.D.), the majority whip and second-ranking member in the Senate. Thune was joined by five original … [Read more...]
340B Advocates Meet in San Diego
February 5, 2019— Hundreds of pharmacists, 340B program directors, and other patient advocates convened in San Diego last week for the 15th Annual 340B Coalition Winter Conference, the largest such gathering to date. The event gave safety-net hospitals, community health centers, Ryan White clinics, and other safety-net providers a chance to discuss the latest developments in … [Read more...]
New Legislation Would Strengthen 340B Program, Demand Transparency, Accountability for Drug Makers
June 13, 2018—Newly introduced legislation would demand accountability and transparency from drug manufacturers participating in the 340B drug pricing program. The bill, sponsored by Rep. Doris Matsui (D-Calif.), is the most significant pro-340B proposal in nearly a decade. Under the Matsui bill, known as the Stretching Entity Resources for Vulnerable Communities (SERV … [Read more...]